Stimulation of the region antero-ventral to the third cerebral ventricle (AV3V) by a cholinergic drug, carbachol, and lesions of the AV3V have been demonstrated in previous studies to either augment or decrease sodium excretion, respectively. Atrial natriuretic peptide (ANP) dramatically increases renal sodium excretion and has been localized to brain areas previously shown to be involved in control of sodium excretion. Consequently, to evaluate a possible role of brain ANP in evoking the changes in renal sodium excretion that follow stimulations or lesions of the AV3V, we determined the effect of injection of carbachol into the AV3V of rats on the concentration of plasma ANP and its content in several neural tissues, the pituitary gland, lungs, and atria. Conversely, the effect of lesions in the AV3V on plasma ANP and the content of the polypeptide in the various organs was determined. Injection of carbachol into the AV3V produced the expected natriuresis, which was accompanied within 20 min by a dramatic rise in the plasma ANP concentration and a rise in ANP content in the medial basal hypothalamus, the neurohypophysis, and particularly the anterior hypophysis but without alterations in the content of ANP in the lungs or the right or left atrium. Conversely, there was a dramatic decline in plasma ANP at both 24 and 120 hr after the AV3V lesions had been placed. This was accompanied by a slight decline in the content of the peptide in the lungs. There was no change in its content in the right atrium at 24 hr after lesions, but there was a significant increase at 120 hr. There was a small decline in the content in the left atrium at 24 hr, followed by a rebound to slightly elevated levels at 120 hr. These small changes contrasted sharply with the dramatic decline in content of the peptide in the medial basal hypothalamus, median eminence, neurohypophysis, choroid plexus, anterior hypophysis, and olfactory bulb. These declines persisted or became greater at 120 hr; except in the olfactory bulb in which the decline was no longer significant. The dramatic increase in plasma ANP after carbachol stimulation of the AV3V that was accompanied by marked elevations in content of the peptide in basal hypothalamus and neuro-and adenohypophysis suggests that the natriuresis resulting from this stimulation is brought about at least in part by release of ANP from the brain. Conversely, the dramatic decline in plasma ANP after AV3V lesions was accompanied by very dramatic declines in content of ANP in these same structures, which suggests that the previously shown decrease in sodium excretion obtained after these lesions may be at least in part due to a decrease in release of ANP from the brain. In view of the much larger quantities of the peptide stored in the atria, it is still possible that changes in atrial release may contribute to the alterations in plasma ANP observed after stimulation or ablation of the AV3V region; however, these results suggest that the dramatic changes in plasma ANP that followed these manipulations may be due to altered release of the peptide from brain structures as well as the atria and lungs.
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The role played by the central nervous system (CNS) in the control of renal sodium excretion has been demonstrated by several authors (1) (2) (3) (4) . Cholinergic or adrenergic stimulation of the medial septal area, medial preoptic area, anterior lateral hypothalamus, and subfornical organ as well as the anterior portion of the third ventricle (AV3V) induces a dose-related natriuresis accompanied by a lesser kaliuresis (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . Thus, considerable evidence indicates that the medial preoptic area, anterior lateral hypothalamus, subfornical organ, AV3V, habenula, stria medullaris, supraoptic nucleus, and medial septal area are organized in a neural circuit involved in the regulation of water and sodium intake and excretion (12, 13, 17) . The AV3V plays a key role in central control of sodium excretion since its stimulation by carbachol (5-17), a cholinergic drug, angiotensin II (All) or hypertonic saline (18) enhances and its destruction blocks sodium excretion in goats (18) and rats (15, 16) .
Atrial natriuretic peptide (ANP) has potent natriuretic and diuretic effects by renal actions. It has been shown by immunocytochemistry, radioimmunoassay, and radioreceptor techniques that ANP and its receptors are also localized in those structures of the CNS related to the control of water and electrolyte balance (19, 20) .
ANP and All appear to have opposite actions in these structures as well as in the periphery in the control of salt and water balance (21) . For example, it has been reported that microinjections of ANP into the third ventricle (3V) or the subfornical organ inhibit water and salt intake, whereas All injected into these sites is a powerful stimulant to both of these appetitive behaviors (21) (22) (23) . ANP acts within the brain to inhibit All release as well as vasopressin release in response to hemorrhage or water deprivation (24) (25) (26) . This peptide blocks All-induced water intake (22) . ANP also is able to inhibit aldosterone release from the adrenal gland, whereas All stimulates its release (27) .
The natriuresis induced by CNS cholinergic and adrenergic stimulation was not prevented by renal denervation or hypophysectomy, but lesions of the median eminence (ME) in rats blocked the natriuretic response to intraventricular inAbbreviations: AV3V, antero-ventral region of the third cerebral ventricle; ANP, atrial natriuretic peptide; CNS, central nervous system; AII, angiotensin II; 3V, third ventricle; ME, median eminence; AP, anterior pituitary; MBH, medial basal hypothalamus; OB, olfactory bulbs; NL, neurohypophysis; CP, choroid plexus. ITo whom reprint requests should be addressed.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. jection of norepinephrine or hypertonic saline; these results suggest that a hormonal pathway mediates the effects ofthese stimuli on sodium excretion (7). Since we have shown that the cholinergic, adrenergic, or osmotic stimulation of tissue adjacent to the 3V induces natriuresis and kaliuresis (5) (6) (7) (8) (9) (10) (11) and since ANP is localized in these structures (19) , in the present experiments, we determined if the effects on sodium excretion of stimulation and ablation of the AV3V region might be mediated, at least in part, by altered ANP release.
MATERIALS AND METHODS
Adult male rats (Wistar strain, weighing 250-280 g) were housed in individual cages and maintained under standard laboratory conditions (23 ± 20C; lights on from 0700 to 1900) with food and water ad libitum.
For the experiments the animals were divided into two experimental groups: (i) Rats with chronically indwelling 3V cannulae were subjected 7-10 days later to carbachol stimulation to study its effect on sodium, potassium, and water excretion. These rats were sacrificed just prior to (0 min) and 20 or 40 min after injection of carbachol into the 3V to study the possible correlation between its effect on natriuresis, kaliuresis, and water excretion with the ANP content in several brain structures, anterior and neural lobe of the pituitary, right and left atria, lungs, and plasma. (ii) Lesions were located in the AV3V, and the rats were killed by decapitation 24 or 120 hr later. The ANP content in several brain structures, anterior and neural lobe of the pituitary, right and left atria, lungs, and plasma was measured in these animals. Control rats with sham AV3V lesions were sacrificed 24 or 120 hr later, and the levels of ANP were measured.
The site oflesions was verified by examining slides of serial frontal sections (7 /Lm). Only rats with destruction of at least 95% of the AV3V region were used. 3V Cannulation. A chronically indwelling guide cannula was surgically implanted into the 3V, as described (28), using 2.5% (vol/vol) tribromoethanol [Aldrich, 1 ml/100 g (body weight), i.p.] to induce anesthesia. After surgical implantation of the guide cannula (23 gauge, stainless steel), the rats received a prophylactic dose of penicillin G procaine (60,000 units, i.m.) and were handled daily for 7-10 days before being utilized in the experiments. The criteria for selection of the animals for the experiments were the presence of cerebrospinal fluid in the 3V guide cannula and the return of their body weight to preoperative values. AV3V Lesions. Rats were anesthetized with ether and placed in a David Kopf stereotaxic instrument. After a longitudinal incision in the scalp, the bregma and lambda were placed at the same horizontal level. An insulated nichrome electrode (26 gauge) with 0.5 mm of the tip exposed was inserted into the brain in the midline, according to the following stereotaxic coordinates: anterior posterior (AP) = 0.3 mm caudal to begma; lateral = 0 mm; vertical = 7.0 mm below the level of the dura mater. The lesion was produced by passing an anodal current of 2 mA for 15 sec. Control rats underwent the same surgical procedures, except that the electrodes were lowered only 6 mm below the dura mater and no current was passed (28) .
Experiments Measuring Sodium and Potassium Excretion and Urinary Volume. Animals utilized in these studies were fasted overnight and given water ad libitum. Just prior to the experiment, the rats were weighed, received a water load equivalent to 5% of their body weight by stomach tube, and placed in individual metabolic cages. One hour later, a second water load, equal in volume to the first, was administered. A total of three urine samples was then collected at 20-min intervals (-20 (29) . Tissue ANP content. After decapitation and blood collection from the trunk as described above, the following tissues were quickly removed and placed in 0.5 ml of 0.1 M acetic acid containing the proteolytic enzyme inhibitors used for plasma: AP, medial basal hypothalamus (MBH), olfactory bulbs (OB), choroid plexus (CP), and left and right atria. The tissues were homogenized with a Polytron. Whole lungs were homogenized in 5 ml of ice-cold 0.1 M acetic acid. The homogenates were centrifuged at high speed at 4°C for 10 min. The supernatant was lyophilized and stored at -20°C until assayed for ANP. Each sample was reconstituted with 500 ,A ofANP buffer, and aliquots of50 and 100 ,ul were taken for radioimmunoassay (29) . The sensitivity and specificity of the ANP radioimmunoassay have been described in detail by Gutkowska et al. (30) .
Statistical Analysis. Using the STATPACK computer program, the Kolmogorov test was applied to define the data distribution. The immunoreactive ANP values for lungs, right and left atrial, plasma, and CNS structures followed a normal distribution. For the CP, hypophysis, and OB, ANP values were normalized after logarithmic transformation since the distribution was not normal. Thereafter, the results from each structure were analyzed by one-way analysis of variance using the Newman-Keuls test to determine significance of differences between treatments (31). (Fig. 1) . The natriuretic response was greater than the kaliuretic response so that the sodium/potassium ratio increased. Since there was also a significant decrease in urine volume (Fig. 1) , the concentrations of both ions increased in the urine samples. The response was maximal during the first 20 min after injection and was still significant between 20 and 40 min. Control injection of intraventricular isotonic saline did not induce any significant changes in the values for urine volume or sodium and potassium excretion.
RESULTS
Plasma ANP concentrations increased significantly and maximally at 20 min after 3V injection of carbachol and ,,(8) (8) I, (5) remained elevated at 40 min (Fig. 2) . The intraventricular injection of isotonic saline did not alter plasma levels of ANP.
Since these values and the initial levels just prior to injection were unchanged, they were pooled as the control value (Fig.  2) . By contrast with the dramatic changes in plasma ANP concentration, the basal values for ANP content in the lung were not significantly changed at 20 or 40 min after 3V injection of carbachol (Fig. 3) . Similarly, there was no significant alteration in the ANP content in either the right or left atria (Fig. 4) . In contrast, the ANP content of the MBH, NL, and AP increased significantly and maximally at 20 min (Fig. 5) . Values remained elevated at 40 min in the MBH, but they were no longer significantly altered from the control content in the NL and AP. In the other CNS structures analyzed, there were no changes between the control and experimental groups.
Experiment 2: Effects of AV3V Lesions on ANP Content in Several Brain Structures, AP, NL, and Plasma. There was a dramatic decline in plasma ANP levels within 24 hr after AV3V lesions; this decline was maintained at 120 hr (Fig. 6) . The ANP content of the lungs was also significantly decreased within 24 hr, and this decrease was maintained at 120 hr, but the degree of decline was only -50% in contrast to the 8-fold decline in plasma concentrations (Fig. 7) . Although the ANP content of the right atrium was not significantly changed at 24 hr after lesions compared to values in sham-operated controls, at 120 hr-the content was significantly increased (Fig. 8) . On the other hand, the values of ANP content of the left atrium were significantly reduced 24 hr after lesion but had significantly increased by 120 hr (Fig. 8) .
There was a marked decline in the content of ANP in the MBH, ME, CP, AP, and OB within 24 hr after AV3V lesions (Fig. 9 ). The only structure in which -ANP content did not decline was the NL. ANP values at 120 hr after lesions were also significantly reduced in all ofthese structures except that the decrease in the OB was no longer significant statistically (Fig. 9) . 
DISCUSSION
Although it has been known for a number of years that CNS stimulation by carbachol could evoke natriuresis (5-11), whereas lesions of the AV3V conversely inhibited salt excretion (3, 15, 16, 21) , the mechanism by which these effects were accomplished was unknown. It is now clear from the results of these experiments that a major factor in evoking these changes in natriuresis is the level of blood ANP. In addition to ANP, recent evidence indicates that there is also a brain natriuretic peptide that has partial sequence homology with ANP (32, 33) . Therefore, the question arises as to whether the changes in ANP that we found actually reflect changes in ANP or possibly reflect brain natriuretic peptide that might crossreact in our immunoassay. There is little or no crossreactivity of the antiserum employed in this study with brain natriuretic peptide (J.G., unpublished data). Consequently, we believe that the changes that we have found reflect changes in ANP and not brain natriuretic peptide.
This study does not prove the origin of the ANP found in plasma after these manipulations. It would appear on the basis of the rapid increase in ANP present in brain structures, in the neural and anterior lobes of the pituitary, and in the ME, that carbachol may stimulate its release from these sites, which then results in an increase in plasma levels of the peptide. This scenario appears quite likely because the changes in atrial content of the peptide were minimal; however, some change in the release of the peptide from the atria FIG. 7 . Effect of AV3V lesions on ANP content of the lungs. P < 0.05 in lesioned versus control. Bars are as in Fig. 6 . cannot be ruled out because the stores of the peptide in the atria are so much larger than those in any brain structure.
Since the total content of ANP in the hypothalamicpituitary region at the onset of carbachol stimulation is less than the content in the total circulating blood volume and since this content increases dramatically after carbachol stimulation, it is apparent that, if the increase in plasma ANP is mediated by increased release of peptide from the brain, then the turnover of brain ANP must increase manyfold.
Conversely, after lesions of the AV3V that lowered plasma ANP levels, there was a concomitant reduction in the content of the peptide in a variety of brain structures and also in neural and anterior lobe of the pituitary. In contrast, there was no change in the content of the peptide in the right atria, its principal source. These results suggest that the major cause of the decrease in plasma ANP after these lesions may be the decrease in release of the peptide from brain sites. Again because of the greater stores of the peptide present in the atria and lungs and the fact that there was an actual transient decline in the content in the left atria and lungs, we cannot rule out participation of decreased release of peptide from these organs as a contributor to the decline in plasma ANP after the lesions.
The results therefore lead us to the following hypothesis. Activation of central natriuretic pathways by carbachol or possibly physiologically by an increase in sodium concentration in the region of the circumventricular organs activates the release of ANP from the brain and possibly also reflexly from the atria; this is the major cause of the natriuresis that ensues. Conversely, lesions in the central pathways, epito- Fig. 6 . **, P < 0.05 in lesioned versus control. mized here by the AV3V, decrease the release ofcentral ANP and may also reflexly decrease the atrial release of the ANP.
Earlier work in which ME lesions abolished the natriuetic response to intraventricular hypertonic saline or norepinephrine (7) are consistent with this concept, but at that time, although a humoral mechanism was postulated, ANP had yet to be discovered. There was then evidence for a hypothalamic natriuretic peptide and on the basis of the present work it would appear that the major hypothalamic natriuretic peptide is ANP.
Further work will be needed to determine the relative contribution of brain ANP to the natriuretic response to volume expansion. Preliminary experiments in our laboratory indicate that lesions of the ME can produce a significant suppression of the increase in plasma ANP that follows volume expansion with intravenous isotonic glucose.
